Dose escalation and personalization in atopic dermatitis: reply to the real-world study by Demirbaş et al. " Dose-dependent effectiveness and patient-reported outcomes with JAK1 inhibitors in atopic dermatitis: a 36-week multicenter real-world cohort."

J Dermatolog Treat. 2026 Dec;37(1):2627102. doi: 10.1080/09546634.2026.2627102. Epub 2026 Feb 5.

Luigi Gargiulo^{1

2}, Matteo Bianco^{1

2}, Luciano Ibba^{1

2}, Sara Di Giulio^{1

2}, Antonio Costanzo^{1

2}, Alessandra Narcisi^{1

2}

¹ Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

No abstract available